visiongain Logo 72dpi.jpg
Lead analyst says: “Global cancer immunotherapy market set to grow to $117bn by 2024”.
12. März 2019 11:18 ET | Visiongain Ltd
London, UK, March 12, 2019 (GLOBE NEWSWIRE) -- Immunotherapeutics and targeted therapies are emerging as promising treatment options for various cancer types. In the biological cancer drug category,...